Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04649307
Status:
COMPLETED
Last Update Posted:
2022-05-24
First Post:
2020-11-24
Brief Title:
Cognitive Behavioral Therapy Following Myocardial Infarction
Sponsor:
Karolinska Institutet
Organization:
Karolinska Institutet
Study Overview
Official Title:
Cognitive Behavioral Therapy Following Myocardial Infarction
Status:
COMPLETED
Status Verified Date:
2022-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MI-CBT
Brief Summary:
Myocardial infarction MI is one of the leading cause s of health loss globally representing a large proportion of general disability Anxiety and depression occur in 20-30 percent of patients following MI and have been identified as risk factors for recurrent adverse cardiac event The purpose of our this study is to develop and evaluate a disease specific cognitive behavioral therapy C BT protocol to reduce cardia anxiety depression increase physical inactivity and quality of life Q oL in patients following MI
Detailed Description:
The study will include 20 patients The MI-specific CBT lasts for 8 weeks and is delivered face-to-face via a secure digital video solution to minimize cancelled sessions because of the COVID-19 pandemic or at the Karolinska Universitetssjukhuset cardiac research unit by licensed psychologists with expertise in CBT for cardiac disease During treatment the psychologists will have direct access to a cardiologist assigned to the project and treatments are conducted in close interdisciplinary collaboration to ensure patient safety
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None